Cornercap Investment Counsel Inc Abbott Laboratories Transaction History

Cornercap Investment Counsel Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $151,719 - $175,663	-1,568 Reduced 8.04%	17,931 $1.74 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $157,085 - $189,866	-1,539 Reduced 7.32%	19,499 $2.12 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $148,796 - $181,447	1,305 Added 6.61%	21,038 $2.49 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $41,937 - $51,349	363 Added 1.87%	19,733 $2.78 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $65,562 - $72,531	-562 Reduced 2.82%	19,370 $2.29 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $2.11 Million - $2.48 Million	19,932 New	19,932 $2.31 Million

3,228

1.3B

8.71M

8.03M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.